Hetastarch
76 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
76
Total Reports
52
Deaths Reported
6840.0%
Death Rate
Active Ingredients
Hetastarch
Administration Routes
IntravenousUnknown
Species Affected
Dog 67
Cat 9
Most Affected Breeds
Retriever - Labrador 12
Domestic Shorthair 7
Chihuahua 4
Maltese 3
Collie - Border 3
Schnauzer - Miniature 3
Terrier - Yorkshire 3
Sheepdog - Shetland 3
Domestic Longhair 2
Boxer (German Boxer) 2
Most Reported Reactions
Vomiting 33
Other abnormal test result NOS 31
Death by euthanasia 29
Lethargy (see also Central nervous system depression in 'Neurological') 26
Hypotension 24
Death 24
Anorexia 22
Anaemia NOS 18
Elevated alanine aminotransferase (ALT) 18
Hypoalbuminaemia 17
Lateral recumbency 16
Elevated serum alkaline phosphatase (SAP) 15
Outcome Breakdown
Euthanized
28 (36.4%)
Died
24 (31.2%)
Ongoing
18 (23.4%)
Recovered/Normal
5 (6.5%)
Recovered with Sequela
1 (1.3%)
Outcome Unknown
1 (1.3%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.